inherited retinal diseases

Dallas’ Nanoscope Therapeutics Hires Chief Technology, Manufacturing Officer

by | Dec 6, 2024
Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotech companies, Nanoscope said.
MORE
Nanoscope Therapeutics Appoints SVP of Regulatory and Quality
by | May 17, 2024
Khandan Baradaran, PhD, was most recently VP of regulatory CMC at Ultragenyx Pharmaceutical, a biopharmaceutical company involved in the research and development of novel products for the treatment of rare and ultra-rare genetic diseases.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.